Story perspectives

Breakthrough Epigenetic Editing Offers Hope for Sickle Cell Treatment

8/18/2025

23 3

Summary

Story summary

Researchers from UNSW Sydney and St. Jude Children's Research Hospital are using epigenetic editing to treat sickle cell disease.
This technique reactivates dormant genes by removing methyl groups without DNA cutting, reducing risks of traditional gene therapies.
Future plans involve animal testing and clinical trials, with potential applications in medicine and agriculture.
Findings highlight the role of methylation in gene regulation, enabling precise and adaptable therapies.

1 of 1

Story summary

Researchers from UNSW Sydney and St. Jude Children's Research Hospital are using epigenetic editing to treat sickle cell disease.
This technique reactivates dormant genes by removing methyl groups without DNA cutting, reducing risks of traditional gene therapies.
Future plans involve animal testing and clinical trials, with potential applications in medicine and agriculture.
Findings highlight the role of methylation in gene regulation, enabling precise and adaptable therapies.